Blood Testing Market Research Report Information By Test Type (Complete Blood Count, Blood Chemistry Tests, and Enzyme Tests), By Disease (Anemia, Infection, and Leukemia), By Method (Manual and Automated), By End-User (Hospitals, and Diagnostic Center), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Blood Testing Market, by Test Type

6.1 Introduction

6.2 Glucose Testing

6.2.1 Market Estimates & Forecast, 2019–2027

6.3 Lipid Panel Testing

6.3.1 Market Estimates & Forecast, 2019–2027

6.4 Direct LDL Testing

6.4.1 Market Estimates & Forecast, 2019–2027

6.5 Prostate Specific Antigen (PSA) Testing

6.5.1 Market Estimates & Forecast, 2019–2027

6.6 Blood Urea Nitrogen (BUN) Testing

6.6.1 Market Estimates & Forecast, 2019–2027

6.7 A1C Testing

6.7.1 Market Estimates & Forecast, 2019–2027

6.8 High Sensitivity C-Reactive Protein (hs-CRP) Testing

6.8.1 Market Estimates & Forecast, 2019–2027

6.9 Vitamin D Testing

6.9.1 Market Estimates & Forecast, 2019–2027

6.10 ALT Testing

6.10.1 Market Estimates & Forecast, 2019–2027

6.11 Thyroid Stimulating Hormone Testing

6.11.1 Market Estimates & Forecast, 2019–2027

6.12 Creatinine Testing

6.12.1 Market Estimates & Forecast, 2019–2027

6.13 Serum Nicotine/Cotinine Testing

6.13.1 Market Estimates & Forecast, 2019–2027

6.14 AST Testing

6.14.1 Market Estimates & Forecast, 2019–2027

6.15 Cortisol Testing

6.15.1 Market Estimates & Forecast, 2019–2027)

6.16 Testosterone Testing

6.16.1 Market Estimates & Forecast, 2019–2027

Chapter 7. Global Blood Testing Market, by Disease

7.1 Introduction

7.2 Anemia

7.2.1 Market Estimates & Forecast, 2019–2027

7.3 Infection

7.3.1 Market Estimates & Forecast, 2019–2027

7.4 Leukemia

7.4.1 Market Estimates & Forecast, 2019–2027

7.5 Hypokalemia

7.5.1 Market Estimates & Forecast, 2019–2027

7.6 Kidney Disorders

7.6.1 Market Estimates & Forecast, 2019–2027

7.7 Heart Attack

7.7.1 Market Estimates & Forecast, 2019–2027

7.8 Coronary Heart Disease

7.8.1 Market Estimates & Forecast, 2019–2027

7.9 Other

Chapter 8. Global Blood Testing Market, by Method

8.1 Introduction

8.2 Manual Blood Culture Testing

8.2.1 Market Estimates & Forecast, 2019–2027

8.3 Automated Blood Culture Testing

8.3.1 Market Estimates & Forecast, 2019–2027

8.3.2 Automated Blood Culture System

8.3.2.1 Market Estimates & Forecast, 2019–2027

8.3.3 Blood Culture Instruments

8.3.3.1 Market Estimates & Forecast, 2019–2027

8.3.4 Others

8.4 Others

Chapter 9. Global Blood Testing Market, by End-User

9.1 Introduction

9.2 Hospital

9.2.1 Market Estimates & Forecast, 2019–2027

9.3 Clinic

9.3.1 Market Estimates & Forecast, 2019–2027

9.4 Diagnostic Center

9.4.1 Market Estimates & Forecast, 2019–2027

9.5 Research Labs

9.5.1 Market Estimates & Forecast, 2019–2027

9.6 Other

Chapter .8 Global Blood Testing Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.1 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 U.K.

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia Pacific

8.5 The Middle East & Africa

8.5.1 United Arab Emirates

8.5.2 Saudi Arabia

8.5.3 Oman

8.5.4 Kuwait

8.5.5 Qatar

8.5.6 Rest of the Middle East & Africa

Chapter 9 Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

9.3.1 Key Developments

Chapter 10 Company Profiles

10.1 Abbott Laboratories Inc.

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials

10.1.4 SWOT Analysis

10.2 Baxter International

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Gen-Probe, Inc.

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Becton Dickinson & Company

10.4.1 Company Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Roche Diagnostics

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.6 Thermo Fisher Scientific Inc.

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.7 Novartis International AG

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Bio-Rad Laboratories Inc.

10.8.1 Company Overview

10.8.2 Product/Business Segment Overview

10.8.3 Financial Overview

10.8.4 Key Development

10.8.5 SWOT Analysis

10.9 Siemens Healthcare

10.9.1 Company Overview

10.9.2 Product Overview

10.9.3 Financial overview

10.9.4 Key Developments

10.10 Cardinal Health

10.10.1 Company Overview

10.10.2 Product Overview

10.10.3 Financial overview

10.10.4 Key Developments

10.11 Danaher Corporation

10.11.1 Company Overview

10.11.2 Product Overview

10.11.3 Financial overview

10.11.4 Key Developments

10.12 Others

Chapter 17 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View Point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Prediction of the Pharmaceutical Industry

Chapter 12 Appendix

LIST OF TABLES

Table 1 Blood Testing Industry Synopsis, 2019–2027

Table 2 Blood Testing Market Estimates & Forecast, 2019–2027, (USD Million)

Table 3 Blood Testing Market, by Region, 2019–2027, (USD Million)

Table 4 Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 5 Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 6 Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 7 Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 8 North America Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 9 North America Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 10 North America Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 11 North America Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 12 U.S. Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 13 U.S. Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 14 U.S. Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 15 U.S. Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 16 Canada Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 17 Canada Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 18 Canada Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 19 Canada Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 20 South America Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 21 South America Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 22 South America Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 23 South America Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 24 Europe Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 25 Europe Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 26 Europe Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 27 Europe Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 28 Western Europe Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 29 Western Europe Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 30 Western Europe Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 31 Western Europe Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 32 Eastern Europe Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 33 Eastern Europe Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 34 Eastern Europe Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 35 Eastern Europe Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 36 Asia Pacific Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 37 Asia Pacific Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 38 Asia Pacific Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 39 Asia Pacific Blood Testing Market, by End-User, 2019–2027, (USD Million)

Table 40 The Middle East & Africa Blood Testing Market, by Test Type, 2019–2027, (USD Million)

Table 41 The Middle East & Africa Blood Testing Market, by Disease, 2019–2027, (USD Million)

Table 42 The Middle East & Africa Blood Testing Market, by Method, 2019–2027, (USD Million)

Table 43 The Middle East & Africa Blood Testing Market, by End-User, 2019–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Blood Testing Market

Figure 3 Segmentation Market Dynamics for Blood Testing Market

Figure 4 Global Blood Testing Market Share, by Test Type 2019

Figure 5 Global Blood Testing Market Share, by Disease 2019

Figure 6 Global Blood Testing Market Share, by Method 2019

Figure 7 Global Blood Testing Market Share, by End-User 2019

Figure 8 Global Blood Testing Market Share, by Region, 2019

Figure 9 Americas Blood Testing Market Share, by Country, 2019

Figure 10 Europe Blood Testing Market Share, by Country, 2019

Figure 11 Asia Pacific Blood Testing Market Share, by Country, 2019

Figure 12 Middle East & Africa Blood Testing Market Share, by Country, 2019

Figure 13 Global Blood Testing Market: Company Share Analysis, 2019 (%)

Figure 14 Abbott Laboratories Inc.: Key Financials

Figure 15 Abbott Laboratories Inc.: Segmental Revenue

Figure 16 Abbott Laboratories Inc.: Geographical Revenue

Figure 17 Baxter International: Key Financials

Figure 18 Baxter International: Segmental Revenue

Figure 19 Baxter International: Geographical Revenue

Figure 20 Gen-Probe, Inc..: Key Financials

Figure 21 Gen-Probe, Inc..: Segmental Revenue

Figure 22 Gen-Probe, Inc..: Geographical Revenue

Figure 23 Becton Dickinson & Company: Key Financials

Figure 24 Becton Dickinson & Company: Segmental Revenue

Figure 25 Becton Dickinson & Company: Geographical Revenue

Figure 26 Roche Diagnostics: Key Financials

Figure 27 Roche Diagnostics: Segmental Revenue

Figure 28 Roche Diagnostics: Geographical Revenue

Figure 29 Thermo Fisher Scientific Inc.: Key Financials

Figure 30 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 31 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 32 Novartis International AG: Key Financials

Figure 33 Novartis International AG: Segmental Revenue

Figure 34 Novartis International AG: Geographical Revenue

Figure 35 Bio-Rad Laboratories Inc.: Key Financials

Figure 36 Bio-Rad Laboratories Inc.: Segmental Revenue

Figure 37 Bio-Rad Laboratories Inc.: Geographical Revenue